99 related articles for article (PubMed ID: 15827049)
1. Disturbed calcium metabolism in a patient with bipolar disorder and impaired renal function.
Caskey FJ; Pickett TM
Nephrol Dial Transplant; 2005 Aug; 20(8):1752-5. PubMed ID: 15827049
[No Abstract] [Full Text] [Related]
2. Acid-base and mineral disorders in children: a review.
Chan JC
Int J Pediatr Nephrol; 1980 Mar; 1(1):54-63. PubMed ID: 6896320
[No Abstract] [Full Text] [Related]
3. Examination of megalin in renal tubular epithelium from patients with Dent disease.
Santo Y; Hirai H; Shima M; Yamagata M; Michigami T; Nakajima S; Ozono K
Pediatr Nephrol; 2004 Jun; 19(6):612-5. PubMed ID: 15052463
[TBL] [Abstract][Full Text] [Related]
4. [Sarcoidosis with calcium-related nephropathy].
Dobin VL; Kalinichev GA; Kokunova TA
Ter Arkh; 1993; 65(2):62-3. PubMed ID: 9133016
[No Abstract] [Full Text] [Related]
5. Magnetic resonance imaging in a patient with chronic lithium nephropathy.
Meier M; Beigel A; Schiffer L; Lotz J; Hiss M; Mengel M; Haller H; Schwarz A
Nephrol Dial Transplant; 2007 Jan; 22(1):278-9. PubMed ID: 16990288
[No Abstract] [Full Text] [Related]
6. Ceftazidime in patients with impaired renal function. Studies on pharmacokinetics and nephrotoxicity.
Thurmann-Nielsen E; Walstad RA; Dahl K; Hellum KB
J Chemother; 1989 Jul; 1(4 Suppl):534-5. PubMed ID: 16312519
[No Abstract] [Full Text] [Related]
7. Fleroxacin pharmacokinetics in healthy volunteers and impaired renal function.
Höffler D; Koeppe P; Metz R; Pech M; Sörgel F
J Chemother; 1989 Jul; 1(4 Suppl):558-60. PubMed ID: 16312531
[No Abstract] [Full Text] [Related]
8. Vitamin D and calcium receptors: links to hypercalciuria.
Bai S; Favus MJ
Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):381-5. PubMed ID: 16775452
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder.
Miller CL; Llenos IC; Dulay JR; Weis S
Brain Res; 2006 Feb; 1073-1074():25-37. PubMed ID: 16448631
[TBL] [Abstract][Full Text] [Related]
10. Aberrant amino acid transport in fibroblasts from patients with bipolar disorder.
Persson ML; Johansson J; Vumma R; Raita J; Bjerkenstedt L; Wiesel FA; Venizelos N
Neurosci Lett; 2009 Jun; 457(1):49-52. PubMed ID: 19429160
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical and immunoblot analysis of Dopamine and cyclic AMP-regulated phosphoprotein, relative molecular mass 32,000 (DARPP-32) in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
Ishikawa M; Mizukami K; Iwakiri M; Asada T
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1177-81. PubMed ID: 17521792
[TBL] [Abstract][Full Text] [Related]
12. Bipolar disorder, homocysteine and white matter hyperintensities.
dos Santos A; da Silva JA; Almeida J; Corrêa BB; Gago J; Xavier M
Bipolar Disord; 2008 Sep; 10(6):748-9. PubMed ID: 18837871
[No Abstract] [Full Text] [Related]
13. [Pathogenesis of a calcium metabolic disorder in glomerulonephritis].
Lazar' AF
Vrach Delo; 1982 Jan; (1):86-8. PubMed ID: 7072221
[No Abstract] [Full Text] [Related]
14. Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder.
Lan MJ; McLoughlin GA; Griffin JL; Tsang TM; Huang JT; Yuan P; Manji H; Holmes E; Bahn S
Mol Psychiatry; 2009 Mar; 14(3):269-79. PubMed ID: 18256615
[TBL] [Abstract][Full Text] [Related]
15. [Mitochondrial dysfunction in bipolar disorder].
Kato T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Apr; 25(2):61-72. PubMed ID: 16220655
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of glucarpidase in subjects with normal and impaired renal function.
Phillips M; Smith W; Balan G; Ward S
J Clin Pharmacol; 2008 Mar; 48(3):279-84. PubMed ID: 18192538
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians.
Fagiolini A; Frank E; Scott JA; Turkin S; Kupfer DJ
Bipolar Disord; 2005 Oct; 7(5):424-30. PubMed ID: 16176435
[TBL] [Abstract][Full Text] [Related]
18. The role of mitochondrial dysfunction in bipolar disorder.
Kato T
Drug News Perspect; 2006 Dec; 19(10):597-602. PubMed ID: 17299601
[TBL] [Abstract][Full Text] [Related]
19. Emerging evidence of the impact of kidney disease on drug metabolism and transport.
Nolin TD; Naud J; Leblond FA; Pichette V
Clin Pharmacol Ther; 2008 Jun; 83(6):898-903. PubMed ID: 18388866
[TBL] [Abstract][Full Text] [Related]
20. Differences in cholesterol and metabolic syndrome between bipolar disorder men with and without suicide attempts.
Vuksan-Cusa B; Marcinko D; Nad S; Jakovljević M
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):109-12. PubMed ID: 19026707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
